China is now at the forefront of space‑based X‑ray astronomy thanks to its new EP satellite, which carries a cutting‑edge Wide‑field X‑ray Telescope (WXT) and a follow‑up X‑ray Telescope (FXT). The WXT uses a novel “lobster‑eye” micro‑pore optical design that can scan an enormous 3,600‑square‑degree swath of the sky in a single glance, detecting X‑rays in the 0.5‑to‑4 keV range. This gives it a sensitivity more than ten times better than current survey instruments like NASA’s Swift/BAT and Japan’s MAXI, opening the door to spotting faint, fast‑evolving cosmic events that were previously invisible. The technology traces back to a 1979 idea by astronomer Angel, but only in the past decade has the lobster‑eye concept matured enough for practical use. China’s National Astronomical Observatories began R&D in 2010, and by 2013, in partnership with the Institute of High Energy Physics, they proposed the EP satellite. After a successful pilot project approval in 2017, a five‑year engineering phase kicked off. Beyond mapping X‑ray bursts, the EP satellite could help solve the puzzling “cosmic dawn” signal detected by the U.S. EDGES experiment, by providing long‑duration, interference‑free observations from space. The mission marks a major leap for Chinese space science and promises to reshape our view of the high‑energy universe.
Read moreScience magazine’s annual “Top Ten Scientific Breakthroughs of 2025” spotlighted four game‑changing advances, with China taking the lead. First, the nation’s massive rollout of solar panels, wind turbines and lithium‑ion storage pushed global renewable‑energy capacity past the world’s total fossil‑fuel output for the first half of the year. Cheap, factory‑made rooftop photovoltaics spread from Europe to South Asia, giving millions of households reliable, low‑cost power. In archaeology, researchers from the Chinese Academy of Sciences and Hebei GEO University announced that ancient human bones unearthed in Harbin belong to the elusive Denisovans, reshaping our picture of early human migration in East Asia. Agricultural scientists at Huazhong Agricultural University identified a “gene switch” that makes rice plants tolerate extreme heat, a discovery that could safeguard staple crops as climate change intensifies. Across the Atlantic, a team at Children’s Hospital of Philadelphia and the University of Pennsylvania performed the first personalized gene‑editing treatment on an infant with a rare genetic disorder, proving that custom‑designed gene therapies can work in real patients. Finally, two new antibiotics targeting drug‑resistant gonorrhea received regulatory approval, offering fresh hope in the fight against a growing public‑health threat. Together, these breakthroughs illustrate how science is rapidly reshaping energy, health, food security and our understanding of human history.
Read moreChina is tackling two of the world’s toughest infectious diseases—tuberculosis (TB) and hepatitis C—by turning high‑priced, long‑duration treatments into affordable, short‑course options. TB still affects millions in China, especially in poorer regions where infection rates are ten times higher than in wealthy cities. A new oral regimen called TB‑TRUST slashes treatment time to 6‑9 months, lifts cure rates above 80 % and drops the total price from over 200,000 yuan to just 30,000‑50,000 yuan. With 80 % of the cost reimbursed by health insurance, patients now pay less than 10,000 yuan out‑of‑pocket. A similar story unfolded with hepatitis C. When the breakthrough drug Sovaldi first hit the U.S. market in 2013, a 12‑week course cost about $84,000—far beyond what most insurers would cover. After patents expired and generic versions entered the market, prices fell dramatically. Egypt, once plagued by a 15 % infection rate, launched a nationwide screening and treatment program backed by insurance, driving the carrier rate down to roughly 0.4 % by 2022. Professor Zhang Wenhong argues that such “re‑innovation” not only narrows the gap between rich and poor patients but also strengthens China’s broader goal of a fair, high‑quality health system for all. By leveraging policy support and focusing on county‑level medical hubs, the country aims to turn these successes into a lasting, nationwide model of health equity.
Read more